Search by Drug Name or NDC
NDC 00409-5534-14 SODIUM BICARBONATE 42 mg/mL Details
SODIUM BICARBONATE 42 mg/mL
SODIUM BICARBONATE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is SODIUM BICARBONATE.
Product Information
| NDC | 00409-5534 |
|---|---|
| Product ID | 0409-5534_84dd5f18-5b16-4181-87c5-fd6cf4df147c |
| Associated GPIs | 79050020002010 |
| GCN Sequence Number | 001179 |
| GCN Sequence Number Description | sodium bicarbonate SYRINGE 0.5MEQ/ML INTRAVEN |
| HIC3 | C0K |
| HIC3 Description | BICARBONATE PRODUCING/CONTAINING AGENTS |
| GCN | 02750 |
| HICL Sequence Number | 000523 |
| HICL Sequence Number Description | SODIUM BICARBONATE |
| Brand/Generic | Generic |
| Proprietary Name | SODIUM BICARBONATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SODIUM BICARBONATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 42 |
| Active Ingredient Units | mg/mL |
| Substance Name | SODIUM BICARBONATE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202679 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-5534-14 (00409553414)
| NDC Package Code | 0409-5534-14 |
|---|---|
| Billing NDC | 00409553414 |
| Package | 10 CARTON in 1 PACKAGE (0409-5534-14) / 1 SYRINGE in 1 CARTON / 10 mL in 1 SYRINGE (0409-5534-24) |
| Marketing Start Date | 2020-08-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |